Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryotec America is a private reproductive-health company commercializing cryopreservation products used in assisted reproductive technology. Its business centers on the Cryotec Method, a vitrification and warming approach for oocytes and embryos originally developed by Dr. Masashige Kuwayama. The company sells consumables and related products for IVF laboratories and fertility clinics rather than developing therapeutic drug candidates. Publicly available materials indicate a commercial-stage business focused on embryo and oocyte preservation, with limited evidence of a traditional biotech drug pipeline. The company appears to operate in the U.S. as a distributor or commercial entity associated with the broader Cryotec/Reprolife product ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CRYOTEC.